Polo Pharmaceuticals Private Limited
About Polo Pharmaceuticals Private Limited
Data last updated:
Polo Pharmaceuticals Private Limited is a private limited company based in Himachal Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 October 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24239HP1995PTC017140. Its GSTIN is 02AACCP6315Q1ZA (Himachal Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹13.21 Lakh. It is led by directors Suresh Kumar and Shobha Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 200 Hpsidcindustrial Area Baddi Solan, Himachal Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.12 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹23.88 Lakh (net margin 1.5%) and EBITDA of ₹64.59 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 31% over five years.
As per MCA filings, the company has open charges of ₹3.07 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Polo Pharmaceuticals Private Limited's registered office is in Himachal Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 200 Hpsidcindustrial Area Baddi Solan, Himachal Pradesh, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Polo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Polo Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Polo Pharmaceuticals Private Limited, buy the company report.
Financials of Polo Pharmaceuticals Private Limited
FY 2025 filings availablePolo Pharmaceuticals Private Limited reported revenue of ₹16.12 Cr (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 31% over five years, including 18% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹64.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Polo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Polo Pharmaceuticals Private Limited
Polo Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar | Director | 10 Oct 1995 | 31 Years 0 Months | Current |
| Shobha Rani | Director | 10 Oct 1995 | 31 Years 0 Months | Current |
Auditor
Polo Pharmaceuticals Private Limited is audited by DHILLON & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHILLON & ASSOCIATES | FY 2024 | 02783N |
Shareholding
The shareholding of Polo Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Polo Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2023 | 100822644 | Others | ₹1.98 Cr | Open | |
| 28 Feb 2015 | 10566614 | Union Bank of India | ₹80 Lakh | Open | |
| 09 Nov 2013 | 10466398 | Union Bank of India | ₹7.5 Lakh | Open | |
| 28 Aug 2002 | 80049975 | Uco Bank | ₹4.15 Lakh | Open | |
| 28 Aug 2002 | 80049976 | Uco Bank | ₹4.15 Lakh | Open |
Total charge records: 7 View all charges
Legal cases
No court or tribunal cases involving Polo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Polo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Polo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCP6315Q1ZA | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Polo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Polo Pharmaceuticals Private Limited has 2 board changes on record since 1995: 2 appointments. The latest: Shobha Rani was appointed as Director on 10 Oct 1995.
Frequently asked questions
Polo Pharmaceuticals is an active private limited company based in Himachal Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 October 1995 (31+ years old) and is registered under CIN U24239HP1995PTC017140.
Polo Pharmaceuticals has 2 current directors:
- Suresh Kumar - Director
- Shobha Rani - Director
The latest financial statements of Polo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Polo Pharmaceuticals is 02AACCP6315Q1ZA, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Polo Pharmaceuticals is U24239HP1995PTC017140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Polo Pharmaceuticals was incorporated on 10 October 1995, making it 31+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Shobha Rani was appointed as Director on 10 Oct 1995. Suresh Kumar was appointed as Director on 10 Oct 1995.
The registered office of Polo Pharmaceuticals is at Plot No 200 Hpsidcindustrial Area Baddi Solan, Himachal Pradesh, India.
Polo Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Polo Pharmaceuticals has open charges of ₹3.07 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
